Pharma and IT stocks faced heavy pressure after Trump’s 100% tariff and H-1B visa fee hike, dragging Nifty lower. Laurus Labs showed a topping pattern while Wockhardt stayed in consolidation. Nifty IT ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback